Biomx Inc (PHGE) Stock Analysis

Biomx Inc (PHGE) is a publicly traded company in the HEALTHCARE sector. It trades at $0.88, carries a market capitalization of $10.55M. This page summarizes the public market data, fundamentals, and frequently asked questions for PHGE, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $0.88
• Market Cap: $10.55M
• EPS: $-37.05
• 52-Week High: $13.70
• 52-Week Low: $0.36

Market Sentiment

Biomx Inc currently has a Neutral sentiment score of 0.02.

About Biomx Inc

BiomX Inc. (PHGE) is an innovative clinical-stage microbiome therapeutics company based in Ness Ziona, Israel, specializing in harnessing both natural and engineered phage technologies to tackle pathogenic bacterial infections. The company is committed to addressing chronic diseases associated with dysbiosis, developing a proprietary pipeline of advanced therapies aimed at treating conditions such as inflammatory bowel disease, cystic fibrosis, and acne. With a focus on delivering transformat...

GNG Research Analysis

GNG Research scores Biomx Inc (PHGE) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PHGE.

Frequently Asked Questions

Does PHGE pay dividends?

Biomx Inc (PHGE) does not currently pay a regular dividend.

What is PHGE's market cap?

Biomx Inc (PHGE) has a market capitalization of $10.55M with a current stock price of $0.88.